Source Search Page
endpts.com
Seven patients diagnosed with blood cancer after Skysona treatment, new data show
2+ day, 15+ hour ago —...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC... ...years after treatment … Bioscience & Technology Business CenterThe University...
endpts.com
Perspective’s early data on lead-based radiopharma asset suggest lower dose did better
2+ day, 2+ hour ago —...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC... ...radiopharma biotech … Bioscience & Technology Business CenterThe University...
endpts.com
Astellas places new bet on gene therapy in $50M upfront deal with UK startup
5+ day, 7+ hour ago —...works to rebuild from an earlier gene therapy setback, Astellas... ...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC...
endpts.com
FDA again raises doubts on Stealth's ultra-rare disease drug ahead of adcomm
4+ day, 17+ hour ago —...Data submitted to the FDA by Stealth BioTherapeutics for its... ...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC...
endpts.com
Teva to pay $450M to settle allegations of kickbacks and generic drug price-fixing
2+ day, 1+ hour ago —...Generics giant Teva Pharmaceuticals will pay $450 million... ...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC...
endpts.com
Exclusive Q&A: FDA's principal deputy commissioner on taking over for Califf, adcomms, accelerated approvals and more...
3+ day, 17+ hour ago —...Deputy Commissioner Namandjé Bumpus would be in line to lead... ...With a new presidential administration next year, FDA Principal...
endpts.com
Former Pfizer CEO and CFO flip on activist and say they now support company
3+ day, 14+ hour ago —...In a late-night reversal, Pfizer’s former CEO and CFO issued... ...they now support the company’s existing management over activist...
endpts.com
Immatics heads to Phase 3 with melanoma cell therapy, seeks to raise $150M
2+ day, 16+ hour ago —...Immatics said its PRAME-targeted T cell therapy shrank tumors... ...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC...
endpts.com
Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech
6+ day, 5+ hour ago —...Global investment manager Oaktree is out with its third life... ...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC...
endpts.com
Shattuck Labs cuts CD47 program and 40% of workforce as it focuses on IBD drug
1+ week, 5+ day ago —...Shattuck Labs is laying off 40% of its workforce and discontinuing... ...MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC...